An Epstein-Barr virus protein interacts with Notch

Journal of Virology

Volumn 75, Issue 1, 2001, Pages 384-395

  Kusano, S ^a   Raab Traub, N ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MEMBRANE PROTEIN; MESSENGER RNA; VIRUS PROTEIN;

ARTICLE; CELLULAR DISTRIBUTION; EPSTEIN BARR VIRUS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VIRUS LATENCY;

ANIMALS; BIOLOGICAL TRANSPORT; CELL NUCLEUS; ENDOPLASMIC RETICULUM; HERPESVIRUS 4, HUMAN; HUMANS; MEMBRANE PROTEINS; OPEN READING FRAMES; RABBITS; RECEPTORS, NOTCH; TUMOR CELLS, CULTURED; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

EID: 0034747703     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.1.384-395.2001     Document Type: Article

References (52)

1. Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jkappa or nuclear localization sequences retain the ability to associate with RBP-Jkappa and activate transcription
2. Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane
3. Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency
4. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma
5. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
6. Cytosolic interaction between deltex and Notch ankyrin repeats implicates deltex in the Notch signaling pathway
7. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma
8. Notch: Neurogenesis is only part of the picture
9. The suppressor of hairless protein participates in notch receptor signaling
10. Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus
11. Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure
12. Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma
13. Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: Evidence for a viral protein expressed in vivo
14. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein
15. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa
16. EBV gene expression in an NPC-related tumour
17. Activated mouse Notch 1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters
18. The shortest path from the surface to the nucleus: RBP-J kappa/Su(H) transcription factor
19. Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Burr virus EBNA2
20. Identification of a novel NOTCH-4/INT-3 RNA species encoding an activated gone product in certain human tumor cell lines
21. Prediction of protein secondary structure using the 3D-1D compatibility algorithm
22. Epstein-Burr virus latent membrane protein 1 is essential for B-lyraphocyte growth transformation
23. Epstein-Barr virus-encoded RK-BARF0 protein expression
24. A simple method for displaying the hydropathic character of a protein
25. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B
26. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation
27. Deltex acts as a positive regulator of Notch signaling through interactions with the Notch ankyrin repeats
28. Human deltex is a conserved regulator of Notch signalling
29. Suppressor of Hairless-independent events in Notch signaling imply novel pathway elements
30. Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts
31. Notch inhibition of E47 supports the existence of a novel signaling pathway
32. NF-κB2 is a putative target gene of activated Notch-1 via RBP-Jκ
33. Kuzbanian controls proteolytic processing of Notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis
34. Pathogenesis of Epstein-Burr virus and its associated malignancies
35. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ (kappa)
36. Structural analyses of the Epstein-Burr virus BamHI A transcripts
37. Notch-1 signalling requires ligand-induced proteolylic release of intracellular domain
38. An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter
39. Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus
40. Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors
41. Nuclear access and action of notch in vivo
42. Gene organization of human NOTCH4 and (CTG)n polymorphism in this human counterpart gene of mouse proto-oneogene Int3
43. Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-J kappa/Su(H)
44. Use of second-site homologous recombination to demonstrate that Epstein- Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro
45. Epstein-Barr virus recombinants from overlapping cosmid fragments
46. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression
47. Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene
48. Notch4 and Wnt-1 proteins function to regulate branching morphogenesis of mammary epithelial cells in an opposing fashion
49. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1
50. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease
51. A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jκ